ArticleBlood2025

Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study.

Ioannis Mantzaris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.